TP53 and invasive breast carcinoma: We sought additional evidence that tumors with elevated TPX2 expression demonstrate an increased incidence of p53 mutation, and analyzed the provisional invasive breast carcinoma cohort within the The Cancer Genome Atlas (TCGA) [46, 47].